Weight loss medications, specifically GLP-1 agonists, are fundamentally altering consumer spending patterns, according to a report by business consultancy EY. Research indicates that as usage of these drugs grows—with projections suggesting up to 30 percent of the Australian adult population could be taking them within a decade—supermarket aisles, hospitality businesses, and retail sectors face a shift in demand toward higher protein, lower-processed goods, and a move away from traditional dining-out habits.
Shifting Grocery Baskets: From Snacks to Fresh Protein
The grocery industry, long driven by the assumption that raw appetite dictates consumption, is seeing a change in how shoppers fill their baskets. Lisa Nijssen-Smith, a report author at EY, stated that while total spending levels remain relatively stable, the composition of those purchases is shifting significantly. Shoppers are increasingly selective, opting for fresh, nutrient-dense ingredients over packaged, salty, or sweet snacks.
This trend is not limited to individuals prescribed the medication. “If that person is doing the grocery shopping for a family, we’re seeing that the entire family will move to healthier options such as fruit and vegetables, more lean protein and reduced snack consumption,” Nijssen-Smith said. Retailers may soon need to adjust their product positioning to cater to this health-conscious demographic, which mirrors shifts already observed in the United States.
Did you know?
EY’s modeling estimates that while roughly 10 percent of Australian adults currently use GLP-1 medications, that figure could triple to 30 percent over the next ten years, potentially creating a long-term structural change in retail demand.
Impact on Hospitality and Social Consumption
The influence of weight loss drugs extends well beyond the supermarket. The hospitality sector is facing a decline in patronage, with 44 percent of GLP-1 users reporting that they are dining out less frequently. When these consumers do choose to eat out, their preferences are changing, with a greater emphasis on quality and smaller portion sizes.
Alcohol consumption is also seeing a “fairly steep decline” among users of these medications. This shift represents a challenge for restaurants and bars that rely on volume-driven sales, suggesting a need for the industry to adapt to a consumer base that is prioritizing health and moderation over traditional dining experiences.
Retail Shifts: Beauty, Grooming, and Fashion
As appetite-suppressing drugs change health outcomes, consumer spending is migrating toward lifestyle and self-care categories. EY’s report highlights that users are refreshing their wardrobes more frequently, likely due to changes in body composition. Additionally, there has been a notable increase in spending on skincare and grooming products, suggesting that the “weight loss journey” is influencing a broader interest in personal presentation.
Future Outlook for New Zealand and Global Markets
While the EY report focuses on the Australian market, the findings serve as a leading indicator for other regions, including New Zealand. Nijssen-Smith noted that Australia is currently experiencing trends that were visible in the United States a few years ago. Companies in other markets can view these patterns as a signal of potential future consumer behavior, allowing them to adjust supply chains and marketing strategies accordingly.
Frequently Asked Questions
- Are people on weight loss medication spending less money at the grocery store?
Not necessarily. According to EY, while shoppers are being more selective about what they buy, they are still spending; they are simply prioritizing fresh, high-protein, and less-packaged items over traditional snacks. - Does the medication affect the shopping habits of non-users?
Yes. Because the primary shopper often buys for a household, the dietary shifts of an individual on GLP-1 medication can influence the entire family’s diet, leading to increased consumption of fruit, vegetables, and lean protein. - How is the hospitality industry being affected?
Research indicates a 44 percent decline in dining out among GLP-1 users, who are also choosing to consume less alcohol and prioritize higher-quality, lower-portion dining experiences.
Are you seeing these shifts in your local supermarket or favorite restaurants? Share your thoughts in the comments below or subscribe to our newsletter for more updates on how health trends are reshaping the modern economy.
Worth a look